Our disruptive Technology
We combine world leading advanced cell engineering with our unique technology to mine the function of the entire genome at an unprecedented single amino acid resolution
Operating Worldwide
Applying our unprecedented technology by a strong team of world leading scientific experts in Europe and China we are capable to deliver the next break-through drug.
ACUS LABORATORIES
We combine haploid cellular systems with unique state of the art genetic screening approaches to launch drug development projects based on novel target structures
ACUS - Our Company in Germany
The Acus Screening Technology has a clear advantage compared to approaches using RNAi or CRISPR/Cas9 technology, that fail to interrogate essential genes, and subsequently fail to identify the exact sites of drug action
JLP HEALTH - Our Experts and Advisors
A team of worldwide experts ignites the fire for groundbreaking discoveries
Our leading Experts
Scientific Advisory Board
Prof. Dr. Josef Penninger, MD
Dr. Norbert Bischofberger
Scientific Experts
Dr. Martin Denzel, PhD
Angal Biotechnology
Angalbio envisions to develop first-in-class treatment opportunities in China based on novel drug target structures emerging from mode of action studies of natural compounds
Our Joint Venture in China
Angalbio is established in Suzhou High Tech Zone as a Joint Venture of JLP Health GmbH with Jiangsu Provincial Industrial Technology Research Institute (JITRI) and Suzhou New High Tech District (SND) to create a leading player in the pharmaceutical market of mainland China
JLP Health Lab - Campus-Vienna-Biocenter
JLP Health Lab - Campus-Vienna-Biocenter